Delivery Order SPE2DB24D2106-SPE2DB25FAUHE
Award Date
1/7/25
Potential Completion Date
1/29/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,997.21, is for the delivery of PROMACTA 25 MG TABLET UU 30S, with a completion date of May 16, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,997.21 firm fixed-price contract is for the provision of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. The contract has no set-aside designation and is a delivery order placed under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999. This IDC, under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,135.35 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. The contract has a completion date of February 19, 2025 and is not associated with any set-aside designation. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ICLUSIG 15 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 10, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract 4600082013 with DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,870.16 contract is for the supply of the drug Iclusig 15 mg tablet in 30-count packages, with a completion date of November 19, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $64,953.36 contract is for the delivery of ICLUSIG 30 MG TABLET 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, SPE2DB25FYM54, valued at $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,357,367 units of the pharmaceutical product ICLUSIG 45 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB, valued at $499,999,999, which enables the DLA to issue firm fixed-price delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product PROMACTA 12.5 MG TABLET. The order has a firm fixed price of $3,999.18 and a completion date of June 4, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...